View from the Thoraxcenter: ESC 23 Late-breaking Science Wrap Up

  • Published:  06 September 2023
  • Likes: 

    Heart Icon

    3

Up Next

View from the Thoraxcenter: ESC 23 Late-breaking Science Wrap Up

  • Published:  06 September 2023
  • Likes: 

    Heart Icon

    3

Average (ratings)
No ratings
Your rating
About the episode

Prof Nicolas Van Mieghem and Dr Joost Daemen discuss the new data from the STOPDAPT-3 trial (NCT04609111). 

This study investigated whether prasugrel monotherapy without aspirin, compared to a 1-month dual therapy with aspirin and prasugrel, can reduce bleeding events after percutaneous coronary intervention (PCI) using cobalt-chromium everolimus-eluting stents (CoCr-EES, XienceTM) in patients with high bleeding risk or those with acute coronary syndrome.

Overview

What are the take-home messages from ESC 2O23?

Join us as we delve into the pivotal results that ignited debates and discussions at ESC Congress 2023. Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) return with their "View from the Thoraxcenter" review, where they analyse the hot line and late-breaking trials presented in Amsterdam.

In this ESC 2023 wrap-up, Prof Van Mieghem and Dr Daemen will dissect the data, evaluating real-world applicability, and distilling findings into actionable insights for clinical practice.


You can either opt to view the comprehensive wrap-up encompassing new data from 15 studies, or you may select and explore the specific studies that pique your interest.

Faculty Biographies

Nicolas M Van Mieghem

Nicolas M Van Mieghem

Full Professor of Interventional Cardiology

Prof Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. Prof Van Mieghem believes that great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors. 

 

Academic History

Prof. Nicolas M. Van Mieghem completed his medical training at the Catholic University of Leuven (Belgium), where he earned both his medical degree and his specialist degree in cardiology. During his time in Leuven, he developed a strong interest in cardiovascular medicine, particularly in the emerging field of minimally invasive cardiac interventions. After finishing his core medical and cardiology training, he pursued multiple advanced…

View full profile
Joost Daemen

Joost Daemen

Interventional Cardiologist

Dr Joost Daemen, MD, PhD is a senior interventional cardiologist at the Thorax Center, Erasmus MC, Rotterdam, NL. Dr Daemen obtained his degree in medicine at the Erasmus University Medical Center, Rotterdam in 2005 and did 2 years of internal medicine training and 4 years of general cardiology training at the Thoraxcenter, Rotterdam. 

Dr Daemen is actively involved in several drug-eluting stent trials and is Principal Investigator of four trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Dr Daemen is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.

View full profile

Comments

You must be to comment. If you are not registered, you can register here.